2011China Practical MedicineRequires access

Clinical Observation on Early Diabetic Nephropathy Treated with Lovastain and Simvastatin

Jian Xu

Open publisher page 0 citations

Abstract

Objective To observe the clinical effiency of lovastain combined simvastatin on early diabetic nephropathy.Methods 89 patients with early diabetic nephropathy and dyslipidemia were randomly divided into control group and observation group.UAER,TG,TC,LDL and CRP in the patients were observed and compared before and after treatment between the observation group by combining treatment using lovastain and simvastatin for two months,and the control group by lovastain alone.Results The level of UAER was decreased significantly in two groups,and compared with the control group,the levels of UAER,TG,TC,LDL and CRP of patients in the observation group decreased significantly(P0.01).Conclusion The combination therapy of lovastain and simvastatin has good effect on decreasing UAER and reducing lipidemia.

About this research paper

What this paper is about

Objective To observe the clinical effiency of lovastain combined simvastatin on early diabetic nephropathy.Methods 89 patients with early diabetic nephropathy and dyslipidemia were randomly divided into control group and observation group.UAER,TG,TC,LDL and CRP in the patients were observed and compared before and after treatment between the observation group by combining treatment using lovastain and simvastatin for two months,and the control group by lovastain alone.Results The level of UAER was decreased significantly in two groups,and compared with the control group,the levels of UAER,TG,TC,LDL and CRP of patients in the observation group decreased significantly(P0.01).Conclusion The combination therapy of lovastain and simvastatin has good effect on decreasing UAER and reducing lipidemia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effiency of lovastain combined simvastatin on early diabetic nephropathy.Methods 89 patients with early diabetic nephropathy and dyslipidemia were randomly divided into control group and observation group.UAER,TG,TC,LDL and CRP in the patients were observed and compared before and after treatment between the observation group by combining treatment using lovastain and simvastatin for two months,and the control group by lovastain alone.Results The level of UAER was decreased significantly in two groups,and compared with the control group,the levels of UAER,TG,TC,LDL and CRP of patients in the observation group decreased significantly(P0.01).Conclusion The combination therapy of lovastain and simvastatin has good effect on decreasing UAER and reducing lipidemia.

Key concepts: Simvastatin, Medicine, Diabetic nephropathy, Dyslipidemia, Urology, Internal medicine, Diabetes mellitus, Proteinuria

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Observation on Early Diabetic Nephropathy Treated with Lovastain and Simvastatin — Research Paper | ScholarLens